Endocannabinoid System Research: Cannabis & PTSD Treatment
This PTSD cannabis trauma meta-analysis examines how cannabis use affects trauma-focused treatments for co-occurring PTSD and substance use disorders. Findings show cannabis does not significantly undermine evidence-based PTSD interventions. This…
Endocannabinoid System Clinical Research: 2024 RCT Finds
A 2024 randomized controlled trial evaluated digital mental health interventions using the Minder mobile app designed for university students. The study assessed improvements in mental health and substance use outcomes during a critical transition…
Cannabinoids in Pediatric Medicine: Evidence-Based Review
Cannabinoid clinical trials pediatric research provides evolving evidence on safety and efficacy in children. This review highlights cautious clinical consideration where conventional treatments fall short. Ongoing studies continue to inform best…
Cannabinoids in Pediatric Care: Evidence-Based Clinical Review
Cannabinoid use in children is an evolving area with limited rigorous evidence. Most data comes from observational studies rather than controlled trials. This review highlights the current clinical evidence and safety considerations for cannabinoids in…
Research on Endocannabinoid System in PTSD and Substance Use
This article reviews endocannabinoid system PTSD substance use research focusing on trauma-focused treatments. Evidence shows these treatments remain effective despite cannabis use. Clinicians should consider this when planning PTSD care.
Cannabinoid Clinical Trials: Cannabis in Student Mental Health
This randomized controlled trial evaluates a digital mental health intervention students can access during the critical university transition. The study focuses on cannabis and other substance use alongside mental health outcomes. Results highlight the…
Clinical Research on Mental Health in Retired Athletes
Mental health retired athletes face elevated rates of depression, anxiety, and cognitive concerns compared to the general population. Clinical research highlights factors like career-ending injuries and repeated head trauma as key influences. Early…
Endocannabinoid System Research: Cannabis & Autism Risk
Peripregnancy cannabis exposure autism risks have been linked to behavioral and developmental differences in children. Research shows varying effects depending on autism spectrum disorder symptoms. This highlights concerns about cannabis use from…
Endocannabinoid System & Maternal Cytokines: Clinical Research
Maternal immune suppression cannabis use during pregnancy is linked to changes in key cytokines. This clinical research highlights the biological effects on maternal immune function. Understanding these effects is critical for counseling pregnant…
Cannabinoid Clinical Trials: Cannabis-Induced Psychosis Risk
Clinical trials reveal that cannabis-induced psychosis risk is significant for developing schizophrenia spectrum and bipolar disorders. This risk underscores the importance of long-term psychiatric follow-up. Early monitoring after cannabis-induced…
